Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Metagenomic Next-generation Sequencing to Identify Microbial DNA in Maternal Plasma in Cases of Preterm Premature Rupture of Membranes

NCT04318470 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT04318470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04318470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Metagenomic Next-generation Sequencing to Identify Microbial DNA in Maternal Plasma in Cases of Preterm Premature Rupture of Membranes
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Completed
Start date
February 12, 2020
Completion date
December 31, 2022
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

preterm rupture of membranes